| PERIOD ENDING | 28-Feb-09 | 31-Jul-08 | 31-Jul-07 | | Total Revenue | 7,505 | 13,056 | 15,267 | | Cost of Revenue | 1,024 | 1,815 | 1,831 | | | Gross Profit | 6,481 | 11,241 | 13,437 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 183 | 323 | 328 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,298 | 10,918 | 13,108 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,026) | (8,194) | (3,146) | | Earnings Before Interest And Taxes | 6,298 | 10,918 | 11,087 | | Interest Expense |
-
| 70 | 63 | | Income Before Tax | 6,298 | 10,848 | 11,024 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (729) | 2,653 | 9,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (729) | 2,653 | 9,900 | | Preferred Stock And Other Adjustments | (1,528) | (3,281) | (3,201) | | | Net Income Applicable To Common Shares | ($2,257) | ($628) | $6,699 |
|
1.52% Nasdaq 0.00%
Income Statement
